Abridge vs DeepScribe
Side-by-side comparison of features, pricing, and ratings
At a glance
| Dimension | Abridge | DeepScribe |
|---|---|---|
| Best for | Large health systems and hospital networks on Epic, with enterprise-wide deployment across specialties and nursing teams. | US specialty practices (oncology, cardiology, GI) and mid-market multi-site groups needing deep EHR integration and specialty-aware note structuring. |
| Pricing | Enterprise only, custom pricing; no self-service or per-seat tiers publicly available. | Custom pricing across Practice, Specialty, and Enterprise tiers; targets mid-market with more transparent feature breakdown. |
| Setup complexity | Requires health-system IT involvement and enterprise contract; integrates deeply with Epic but needs organizational buy-in. | Faster to adopt for specialty practices; uses bidirectional EHR integration with lighter IT overhead than full enterprise platforms. |
| Strongest differentiator | Contextual Reasoning Engine with upcoming integration to UpToDate, NEJM, JAMA for evidence-linked documentation; strong hospital brand adoption (Mayo, Johns Hopkins). | Specialty-aware structuring with Flatiron/OnTada integrations for oncology and cardiology; Customization Studio learns provider note style over time. |
DeepScribe vs Abridge: For specialty practices needing deep specialty-aware notes and EHR write-back, DeepScribe wins due to its tailored approach for oncology, cardiology, and GI with Flatiron/OnTada integration and style learning. For large health systems deploying ambient AI enterprise-wide across multiple specialties and nursing units, Abridge is the stronger choice because of its proven deployment at top health systems (Mayo, Johns Hopkins, Kaiser), Epic-first integration, and upcoming evidence-linked clinical decision support. Abridge is the winner for health systems; DeepScribe leads for specialty practices.
Enterprise-grade AI for clinical conversations, trusted by leading health systems
Visit WebsiteFeature-by-feature
Core Capabilities: Abridge vs DeepScribe
Both platforms capture doctor-patient conversations in real time and generate structured clinical notes. Abridge’s strength lies in its Contextual Reasoning Engine, which uses generative AI to interpret the full clinical nuance and produce billable ICD-10 suggestions. DeepScribe counters with specialty-aware structuring that goes beyond a generic note; it tailors output for fields like oncology and cardiology. In a head-to-head, Abridge’s enterprise-grade contextual reasoning and upcoming integration with medical journals (UpToDate, NEJM, JAMA) give it the edge for complex multispecialty environments. DeepScribe wins for specialty practices needing workflow-specific detail and coding (E/M, ICD-10, HCC) with audit-ready documentation.
AI/Model Approach: Abridge vs DeepScribe
Abridge leverages a proprietary generative AI model with a Contextual Reasoning Engine that references external clinical evidence (via partnerships with UpToDate, NEJM, JAMA) to enhance note accuracy and decision support. DeepScribe uses a more focused model that learns each provider’s note style through its Customization Studio, adapting phrasing, level of detail, and structure over time. While Abridge’s approach emphasizes evidence-linked, context-aware documentation at scale, DeepScribe’s model prioritizes personalization and specialty-specific nuances. For large hospitals that require consistency across hundreds of providers, Abridge’s model is more robust; for small- to mid-size specialty groups where clinician adoption hinges on personalization, DeepScribe’s approach leads.
Integrations & Ecosystem: Abridge vs DeepScribe
Abridge integrates natively with Epic (Haiku to Hyperdrive), Cerner, Athenahealth, and MEDITECH, making it a natural fit for health systems already on Epic. It also connects to UpToDate, NEJM, and JAMA for evidence-rich documentation (some pending). DeepScribe covers Epic, Cerner, athenahealth, eClinicalWorks, plus specialty-specific systems like Flatiron and OnTada for oncology, and OMS and MM20 for dental/chiropractic. DeepScribe’s breadth in specialty EHRs gives it an edge for oncology and cardiology practices that require direct write-back into these niche systems. Abridge wins for large Epic-dominant health systems; DeepScribe wins for specialty practices with non-Epic or niche EHR needs.
Performance & Scale: Abridge vs DeepScribe
Abridge reports a 86% reduction in after-hours documentation for physicians at deployed health systems and is recognized as a 2026 Market Leader in Ambient AI by KLAS. It’s designed for enterprise-wide rollout across thousands of clinicians and multiple care settings. DeepScribe claims an 80% clinician adoption rate within its specialty customer base, a strong metric showing engagement and retention. While both handle ambient audio capture and real-time note generation, Abridge’s track record with large health systems (Mayo, Johns Hopkins, Kaiser Permanente, Duke Health) demonstrates proven scale. DeepScribe’s adoption numbers suggest high satisfaction among specialty practices, but it hasn’t published large-system benchmarks.
Developer Experience & Workflow: Abridge vs DeepScribe
Abridge focuses on embedded workflow within Epic, allowing clinicians to stay in their existing environment without switching interfaces. Its upcoming features for nursing documentation and revenue cycle management show a broad workflow vision. DeepScribe’s workflow shines in specialty clinic settings: SmartPrep generates pre-visit context from prior records, and DeepScribe Assist surfaces decision-support cues without breaking flow. The Customization Studio reduces long-term adjustment as the model learns provider preferences. For large hospital IT departments, Abridge’s deep Epic integration and single-vendor approach simplify deployment. For specialty group CTOs who need a flexible, provider-adaptive solution, DeepScribe offers a more tailored workflow.
Pricing compared
Abridge pricing (2026)
Abridge operates on an enterprise-only pricing model with custom quotes. Details are not publicly published; the only listed plan is 'Enterprise' with features including real-time documentation, EHR integration, and clinical AI. Pricing varies by health system size, number of providers, and deployment scope. As of 2026, Abridge does not offer a self-service or per-seat tier. Prospective buyers must contact sales for a quote. Expected costs are high, reflecting the enterprise-grade infrastructure and deep Epic integration.
DeepScribe pricing (2026)
DeepScribe offers three custom-priced tiers: Practice (ambient AI scribe, EHR integration, Customization Studio), Specialty (adds specialty-tuned models, SmartPrep, AI Coding, DeepScribe Assist), and Enterprise (multi-site rollout, admin/RBAC/audit, BAA, SLA, dedicated success). Like Abridge, specific prices are not public; however, the tiered structure suggests a range from lower per-provider costs for the Practice tier up to higher enterprise contracts. DeepScribe targets mid-market specialty practices, so its pricing is likely more competitive for groups of 5–50 providers compared to Abridge’s health-system focus.
Value-per-dollar: DeepScribe vs Abridge
For a 10-provider cardiology practice, DeepScribe likely offers better value per dollar because its Specialty tier directly addresses cardiology-specific note structuring and integrates with common cardiology EHRs (e.g., Epic, but also niche systems). The Customization Studio reduces documentation time as the AI adapts to each clinician. Abridge’s enterprise pricing and heavy Epic dependency would be overkill and cost-prohibitive for such a practice. For a 500-provider hospital network on Epic, Abridge provides better value through enterprise-wide deployment, nursing documentation support, and revenue cycle integration. Its Contextual Reasoning Engine and evidence links (UpToDate, NEJM, JAMA) justify the higher price. DeepScribe’s lack of large-system benchmarks and narrower workflow scope makes it less cost-effective at scale.
Who should pick which
- Large health system CTO (1,000+ providers on Epic)Pick: Abridge
Abridge’s deep Epic integration, enterprise deployment at Mayo/Johns Hopkins, and nursing/revenue cycle features support system-wide adoption.
- Mid-market oncology practice (10-50 providers using Flatiron)Pick: DeepScribe
DeepScribe integrates with Flatiron and OnTada, offers specialty-aware structuring for oncology, and provides AI Coding with audit-ready documentation.
- Solo family medicine clinician on a tight budgetPick: DeepScribe
DeepScribe’s Practice tier likely has lower minimum commitment than Abridge’s enterprise pricing, and the Customization Studio helps a solo provider tailor notes.
- Multi-specialty ambulatory clinic (50 providers, Epic-only)Pick: Abridge
Abridge’s coverage across specialties and real-time prior authorization feature (announced Aug 2025) streamline revenue cycle for a multispecialty setting.
- Cardiology group (5 providers, using Cerner)Pick: DeepScribe
DeepScribe integrates with Cerner and provides specialty-aware structuring for cardiology, while Abridge’s Epic-first integration may be less seamless with Cerner.
Frequently Asked Questions
What is the pricing for Abridge vs DeepScribe?
Both offer custom pricing. Abridge has one enterprise plan, typically for large health systems. DeepScribe has three tiers (Practice, Specialty, Enterprise) targeting mid-market specialty groups. Neither publishes public prices; contact sales for quotes.
Can I use DeepScribe if my clinic is on Epic?
Yes, DeepScribe integrates with Epic bidirectionally, as well as Cerner, athenahealth, eClinicalWorks, and specialty systems. It works well for Epic-based specialty practices, though Abridge has deeper Epic optimization for large hospital networks.
Which tool supports oncology-specific workflows better?
DeepScribe is stronger for oncology due to its integrations with Flatiron and OnTada, and its AI Coding (E/M, ICD-10, HCC) is designed for audit-ready documentation common in oncology billing.
How steep is the learning curve for clinicians?
Both tools use ambient listening with minimal user input. DeepScribe’s Customization Studio gradually adapts to each provider’s note style, reducing long-term learning curve. Abridge is seamless for clinicians already on Epic but requires initial IT setup.
Is Abridge suitable for a small private practice?
Generally no. Abridge is enterprise-only with custom pricing and requires health-system IT involvement. Solo practitioners will find DeepScribe’s Practice tier more accessible and affordable.
Do these tools offer a free trial?
Neither tool publicly advertises a free trial. DeepScribe may offer demos or pilots for specialty practices; Abridge typically engages through enterprise proof-of-concept deployments with health systems.
Which tool has better compliance and security certifications?
Both are HIPAA compliant. DeepScribe additionally holds SOC 2 Type II, offers AES-256 encryption, MFA, and SSO. Abridge also meets HIPAA and enterprise security standards but does not list SOC 2 publicly. For health systems needing HITRUST, neither currently advertises it.
Can I customize the notes to match my personal style?
DeepScribe’s Customization Studio explicitly learns each provider’s phrasing, detail level, and structure over time. Abridge provides context-aware notes but does not emphasize individual style learning; its strength is consistent, evidence-linked documentation across an organization.
Which tool is better for multi-site hospital systems?
Abridge is built for enterprise-wide deployment and has been adopted by large multi-site systems like Mayo Clinic and Kaiser Permanente. DeepScribe’s Enterprise tier supports multi-site rollout but is more focused on mid-market specialty groups.
What is the main difference between Abridge and DeepScribe in 2026?
Abridge targets large health systems with deep Epic integration, a Contextual Reasoning Engine, and upcoming evidence links (UpToDate, NEJM, JAMA). DeepScribe targets US specialty practices with specialty-aware structuring, Flatiron/OnTada integration, and provider style learning. Choose based on your organization’s size and specialty focus.
Last reviewed: May 12, 2026